← Back to all trials
Recruiting
NCT05599035
Sleep Disorder in Parkinson Disease and rTMS
Conditions: Sleep Disorder, Parkinson Disease
Sex: All
Healthy volunteers: 1
Phase: NA
Enrollment: 36
Sponsor: Assiut University
Location: Egypt
Summary
The crude prevalence rate of Parkinson's disease in Upper Egypt governorates ranging from 557-436/100,000 (Assiut and Qena governorates respectively) which was one of the highest prevalence of PD around the world .Parkinson's disease patients report having complaints of disrupted sleep anywhere from 60 to 98 %.
This is one of the most common non-motor symptoms, and it is a substantial contributor to the diminished quality of life associated with Parkinson's disease.
PD patients have poor sleep maintenance and fragmentation (Comella 2007, Khedr et al. 2013).
Khedr et al (2013) found that; 78.6% out of 112 patients with PD had sleep disturbances with the commonest complaint being difficulty getting to sleep at night or staying asleep (46.4%) followed by vivid nightmares and night terrors (27.7%).
In other studies, 80-90% of PD patients have had sleep difficulty with virtually all patients having symptoms at some time in the course of the disease .
Eligibility Criteria
Inclusion Criteria:diagnosis of PD was done according to UK Brain bank Criteria for diagnosis of PD.
Out of them we selected only patients with sleep disturbance All patients fulfilled by Parkinson's disease sleep scale (PDSS).Exclusion Criteria:Patients with PD with disturbed conscious level, severe cognitive impairment, psychosis, and medical problems such as (Renal failure, Liver cell Failure, Respiratory Failure, and endocrinal impairment), patients with other types of Parkinsonism as (Multisystem atrophy, supranuclear palsy, and encephalitic Parkinsonism) and patients had contraindication of magnetic stimulation (metallic piece, pacemaker, epilepsy) were also excluded from the study
Source: ClinicalTrials.gov (NCT05599035). StuddyBuddy aggregates publicly available trial information.